RU2003125554A - Природные антитела, активные против вируса иммунодефицита человека (вич) - Google Patents

Природные антитела, активные против вируса иммунодефицита человека (вич) Download PDF

Info

Publication number
RU2003125554A
RU2003125554A RU2003125554/15A RU2003125554A RU2003125554A RU 2003125554 A RU2003125554 A RU 2003125554A RU 2003125554/15 A RU2003125554/15 A RU 2003125554/15A RU 2003125554 A RU2003125554 A RU 2003125554A RU 2003125554 A RU2003125554 A RU 2003125554A
Authority
RU
Russia
Prior art keywords
hiv
human
immunodeficiency virus
human immunodeficiency
fraction
Prior art date
Application number
RU2003125554/15A
Other languages
English (en)
Inventor
Радмила МЕТЛАС (GB)
Радмила МЕТЛАС
Original Assignee
Дайафарм Лимитед (GB)
Дайафарм Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI20010500 external-priority patent/ITMI20010500A1/it
Priority claimed from IT2001MI002285A external-priority patent/ITMI20012285A1/it
Application filed by Дайафарм Лимитед (GB), Дайафарм Лимитед filed Critical Дайафарм Лимитед (GB)
Publication of RU2003125554A publication Critical patent/RU2003125554A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Claims (5)

1. Фармацевтический препарат, содержащий человеческие антитела против общей фракции иммуноглобулина G (IgG) человека.
2. Фармацевтический препарат по п.1, где указанные человеческие антитела получают путем аффинной хроматографии сывороток крови нормальных, не инфицированных вирусом иммунодефицита человека (ВИЧ) индивидуумов с использованием смол, связанных с общей фракцией IgG человека.
3. Применение человеческих антител против общей фракции IgG человека для изготовления лекарства для предупреждения или лечения инфекций ВИЧ.
4. Применение по п.3 для пассивной иммунотерапии инфекций ВИЧ-1.
5. Применение по пп.3 и 4 человеческих антител, полученных путем аффинной хроматографии сывороток крови нормальных, не инфицированных ВИЧ индивидуумов с использованием смол, связанных с общей фракцией IgG человека.
RU2003125554/15A 2001-03-09 2002-03-06 Природные антитела, активные против вируса иммунодефицита человека (вич) RU2003125554A (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
ITMI2001A000500 2001-03-09
ITMI20010500 ITMI20010500A1 (it) 2001-03-09 2001-03-09 Auto-anticorpi naturali e il loro uso nella terapia di malattie da virus dell'immunodeficienza umana
ITMI2001A002285 2001-10-31
IT2001MI002285A ITMI20012285A1 (it) 2001-10-31 2001-10-31 Anticorpi naturali attivi contro il virus hiv

Publications (1)

Publication Number Publication Date
RU2003125554A true RU2003125554A (ru) 2005-02-10

Family

ID=26332768

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003125554/15A RU2003125554A (ru) 2001-03-09 2002-03-06 Природные антитела, активные против вируса иммунодефицита человека (вич)

Country Status (28)

Country Link
US (2) US20040106771A1 (ru)
EP (1) EP1366080B1 (ru)
JP (1) JP4601252B2 (ru)
KR (1) KR100871455B1 (ru)
CN (1) CN1494554A (ru)
AP (1) AP2003002852A0 (ru)
AT (1) ATE346870T1 (ru)
AU (1) AU2002257620B2 (ru)
BR (1) BR0207931A (ru)
CA (1) CA2440131A1 (ru)
CY (1) CY1108852T1 (ru)
CZ (1) CZ20032418A3 (ru)
DE (1) DE60216422T2 (ru)
DK (1) DK1366080T3 (ru)
EE (1) EE200300377A (ru)
ES (1) ES2278022T3 (ru)
HR (1) HRP20030701A2 (ru)
HU (1) HUP0303423A3 (ru)
IL (2) IL157753A0 (ru)
MX (1) MXPA03007976A (ru)
NO (1) NO20033934L (ru)
PL (1) PL366785A1 (ru)
PT (1) PT1366080E (ru)
RS (1) RS51011B (ru)
RU (1) RU2003125554A (ru)
SI (1) SI1366080T1 (ru)
TN (1) TNSN03066A1 (ru)
WO (1) WO2002072637A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100330102A1 (en) 2009-06-26 2010-12-30 Wezen Biopharmaceuticals Srl A Socio Unico Immunoglobulin preparation for the treatment of hiv-1 infection

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639513A (en) * 1984-02-02 1987-01-27 Cuno Inc. Intravenously injectable immunoglobulin G (IGG) and method for producing same
US5788687A (en) * 1994-02-01 1998-08-04 Caphco, Inc Compositions and devices for controlled release of active ingredients
US5982866A (en) * 1997-04-25 1999-11-09 At&T Corporation Method and apparatus for forwarding caller identification for a credit card or calling card call to an automatic number identification system of a telephone network
DE19815430B4 (de) * 1998-04-07 2005-12-15 T-Mobile Deutschland Gmbh Verfahren zum Verbindungsaufbau von einem Mobilfunknetz zu einer Zielrufnummer eines privaten Kommunikationsnetzes
ES2527915T3 (es) * 1998-06-09 2015-02-02 Csl Behring Ag Producto de inmunoglobulina G (IgG) líquido
WO2000078017A1 (en) * 1999-06-14 2000-12-21 Wilshire Cellular, Inc. Method and apparatus for communicating with one of plural devices associated with a single telephone number
US6818247B1 (en) * 2000-03-31 2004-11-16 Advanced Cardiovascular Systems, Inc. Ethylene vinyl alcohol-dimethyl acetamide composition and a method of coating a stent
US6970719B1 (en) * 2000-06-15 2005-11-29 Sprint Spectrum L.P. Private wireless network integrated with public wireless network
US7336668B2 (en) * 2001-09-24 2008-02-26 Christopher Lyle Adams Communication management system with line status notification for key switch emulation
US8040873B2 (en) * 2001-11-07 2011-10-18 Alcatel Lucent Distributed integration of legacy PBX system with SIP networks
US20030105799A1 (en) * 2001-12-03 2003-06-05 Avaz Networks, Inc. Distributed processing architecture with scalable processing layers
US7546143B2 (en) * 2001-12-18 2009-06-09 Fuji Xerox Co., Ltd. Multi-channel quiet calls
US7146163B2 (en) * 2002-10-01 2006-12-05 Isp Operator Corporation Sender-address-based telecommunications operator callback system and method
US20040086093A1 (en) * 2002-10-29 2004-05-06 Schranz Paul Steven VoIP security monitoring & alarm system
US7904068B2 (en) * 2003-06-06 2011-03-08 At&T Intellectual Property I, L.P. System and method for providing integrated voice and data services utilizing wired cordless access with unlicensed spectrum and wired access with licensed spectrum
US7715413B2 (en) * 2003-10-23 2010-05-11 Emerj, Inc. Multi-network exchange system for telephony applications
CN1906956B (zh) * 2004-01-14 2010-04-21 捷讯研究有限公司 用于无线供应移动通信设备的系统及方法
US8254989B2 (en) * 2004-07-29 2012-08-28 Sprint Spectrum L.P. Method and system for account balance restriction on application of cellular-PBX integration service
CA2550721A1 (en) * 2005-06-22 2006-12-22 Newstep Networks, Inc. Method and system for a communications session join function to facilitate the provision of enhanced communications services
US20070094374A1 (en) * 2005-10-03 2007-04-26 Snehal Karia Enterprise-managed wireless communication

Also Published As

Publication number Publication date
CN1494554A (zh) 2004-05-05
HUP0303423A2 (hu) 2004-01-28
TNSN03066A1 (en) 2005-12-23
PT1366080E (pt) 2007-03-30
US20040106771A1 (en) 2004-06-03
PL366785A1 (en) 2005-02-07
CY1108852T1 (el) 2014-07-02
AU2002257620B2 (en) 2007-09-13
CA2440131A1 (en) 2002-09-19
IL157753A (en) 2010-04-29
EP1366080A1 (en) 2003-12-03
JP2004532198A (ja) 2004-10-21
IL157753A0 (en) 2004-03-28
NO20033934L (no) 2003-11-06
DE60216422D1 (de) 2007-01-11
JP4601252B2 (ja) 2010-12-22
HUP0303423A3 (en) 2005-11-28
NO20033934D0 (no) 2003-09-05
US20070020290A1 (en) 2007-01-25
YU70103A (sh) 2006-05-25
AP2003002852A0 (en) 2003-09-06
DE60216422T2 (de) 2007-11-29
RS51011B (sr) 2010-10-31
EE200300377A (et) 2003-10-15
HRP20030701A2 (en) 2006-06-30
DK1366080T3 (da) 2007-03-26
CZ20032418A3 (cs) 2004-02-18
WO2002072637A1 (en) 2002-09-19
ES2278022T3 (es) 2007-08-01
KR100871455B1 (ko) 2008-12-03
BR0207931A (pt) 2004-03-02
EP1366080B1 (en) 2006-11-29
KR20040000401A (ko) 2004-01-03
ATE346870T1 (de) 2006-12-15
MXPA03007976A (es) 2004-10-15
SI1366080T1 (sl) 2007-06-30

Similar Documents

Publication Publication Date Title
EA200801798A1 (ru) Виросомоподобные везикулы, содержащие антигены, производные от gp41
EA200200724A1 (ru) Вакцина для профилактической или терапевтической иммунизации против вируса иммунодефицита человека (вич)
ATE241696T1 (de) Rekombinanter hiv-spezifischer impfstoff aus poxviru
WO2002020554A3 (en) Hiv peptides from conserved regions in gag p17 and 924 and their application in e.g. vaccines
HUP0202502A2 (hu) Virális fertőzőképességet blokkoló peptidek és eljárások ezek alkalmazására
WO2020252393A8 (en) Compositions and methods for the treatment of human immunodeficiency virus
WO2005028496A3 (en) Vaccine for treatment and prevention of herpes simplex virus infection
WO2005076001A3 (en) A polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an hiv virus in an individual
WO2002057314A3 (en) Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes
RU2003125554A (ru) Природные антитела, активные против вируса иммунодефицита человека (вич)
EP1572721A4 (en) PREVENTING AND TREATING VCH INFECTION USING ANTIBODIES AGAINST CONFORMATIONAL AND LINEAR EPITOPES
JP2002508338A5 (ru)
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
EP0250128A3 (en) Novel virus isolated from patients with aids
DE69433057D1 (de) Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus
RU96116005A (ru) Штамм hominis immunodeficiti virus (hiv-i) вич-i/россия/гм-12-95 (ru1295) субтипа в для диагностических и вакцинных препаратов
HUP0302416A2 (hu) Tisztított hepatitis-C vírusmembrán-proteinek diagnosztikai és terápiás célú alkalmazása
CA2350127A1 (en) Avipox vector coding an hiv antigen and a cytokine
WO1988007376A1 (en) Remedy for viral diseases
WO2000000223A3 (de) ANTIVIRALE UND ANTIRETROVIRALE RADIOIMMUNPHARMAKA AUF DER BASIS VON α- UND β-STRAHLERN
DK192990A (da) Laegemiddel til behandling eller forhindring, ved passiv immunisering, af hiv infektion og fremgangsmaader til fremstilling deraf
JP2004532198A5 (ru)
DE60231605D1 (de) Immunomodulator zur bekämpfung von durch humanen immunschwächevirus (hiv) vermittelte krankheiten/infektionen
FR2614025B1 (fr) Peptides susceptibles d'etre reconnus par des anticorps induits contre des retrovirus d'immunodeficience humaine (virus hiv) leurs applications au diagnostic des infections dues a certains de ces virus et, le cas echeant, a la vaccination contre le sida
DK0470989T3 (da) Anvendelse af monoklonale anti-beta2 mikroglobulin antistoffer

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20061208